Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy. [electronic resource]
Producer: 20050125Description: 190-5 p. digitalISSN:- 0031-7012
- 3',5'-Cyclic-GMP Phosphodiesterases -- antagonists & inhibitors
- Animals
- Cyclic Nucleotide Phosphodiesterases, Type 5
- Diabetes Mellitus, Experimental -- complications
- Diabetic Neuropathies -- complications
- Dose-Response Relationship, Drug
- Female
- Hyperalgesia -- complications
- Male
- Methylene Blue -- pharmacology
- Mice
- NG-Nitroarginine Methyl Ester -- pharmacology
- Pain Threshold -- drug effects
- Phosphodiesterase Inhibitors -- therapeutic use
- Piperazines -- therapeutic use
- Purines
- Rats
- Rats, Wistar
- Sildenafil Citrate
- Sulfones
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.